Correlation Between PAVmed and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PAVmed and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PAVmed and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PAVmed Inc and Neuropace, you can compare the effects of market volatilities on PAVmed and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PAVmed with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of PAVmed and Neuropace.

Diversification Opportunities for PAVmed and Neuropace

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between PAVmed and Neuropace is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding PAVmed Inc and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and PAVmed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PAVmed Inc are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of PAVmed i.e., PAVmed and Neuropace go up and down completely randomly.

Pair Corralation between PAVmed and Neuropace

Given the investment horizon of 90 days PAVmed Inc is expected to generate 1.43 times more return on investment than Neuropace. However, PAVmed is 1.43 times more volatile than Neuropace. It trades about 0.07 of its potential returns per unit of risk. Neuropace is currently generating about 0.06 per unit of risk. If you would invest  64.00  in PAVmed Inc on December 30, 2024 and sell it today you would earn a total of  11.00  from holding PAVmed Inc or generate 17.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PAVmed Inc  vs.  Neuropace

 Performance 
       Timeline  
PAVmed Inc 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, PAVmed displayed solid returns over the last few months and may actually be approaching a breakup point.
Neuropace 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

PAVmed and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PAVmed and Neuropace

The main advantage of trading using opposite PAVmed and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PAVmed position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind PAVmed Inc and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data